ATE285228T1 - Arzneistoffverabreichungsystem zur verzögerten, völlstandigen wirkstoffabgabe im verdauungstrakt - Google Patents
Arzneistoffverabreichungsystem zur verzögerten, völlstandigen wirkstoffabgabe im verdauungstraktInfo
- Publication number
- ATE285228T1 ATE285228T1 AT00939503T AT00939503T ATE285228T1 AT E285228 T1 ATE285228 T1 AT E285228T1 AT 00939503 T AT00939503 T AT 00939503T AT 00939503 T AT00939503 T AT 00939503T AT E285228 T1 ATE285228 T1 AT E285228T1
- Authority
- AT
- Austria
- Prior art keywords
- core
- inner coat
- coat
- drug
- insoluble
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/906—Drug delivery
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/325,748 US6632451B2 (en) | 1999-06-04 | 1999-06-04 | Delayed total release two pulse gastrointestinal drug delivery system |
PCT/US2000/015185 WO2000074655A2 (en) | 1999-06-04 | 2000-06-02 | Delayed total release two pulse gastrointestinal drug delivery system |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE285228T1 true ATE285228T1 (de) | 2005-01-15 |
Family
ID=23269264
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00939503T ATE285228T1 (de) | 1999-06-04 | 2000-06-02 | Arzneistoffverabreichungsystem zur verzögerten, völlstandigen wirkstoffabgabe im verdauungstrakt |
Country Status (8)
Country | Link |
---|---|
US (1) | US6632451B2 (de) |
EP (1) | EP1189601B1 (de) |
AT (1) | ATE285228T1 (de) |
AU (1) | AU780141B2 (de) |
CA (1) | CA2375714C (de) |
DE (1) | DE60016920T2 (de) |
IL (2) | IL146708A0 (de) |
WO (1) | WO2000074655A2 (de) |
Families Citing this family (90)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6525018B1 (en) | 1999-05-17 | 2003-02-25 | The General Hospital Corp. | Treating eye disorders using intestinal trefoil proteins |
GB9923045D0 (en) * | 1999-09-29 | 1999-12-01 | Novartis Ag | New oral formulations |
US6544555B2 (en) | 2000-02-24 | 2003-04-08 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
US20020068078A1 (en) | 2000-10-13 | 2002-06-06 | Rudnic Edward M. | Antifungal product, use and formulation thereof |
JP4633329B2 (ja) * | 2001-01-12 | 2011-02-16 | サン・ファーマ・アドバンスド・リサーチ・カンパニー・リミテッド | スペーストドラッグデリバリーシステム |
NZ528607A (en) * | 2001-03-15 | 2007-11-30 | Enteron Pharmaceuticals Inc | Method of treating inflammatory GI disorders using topically active corticosteroids to reduce symptoms without causing the side effects associated with systemic steroid administration |
WO2002080887A2 (en) * | 2001-04-10 | 2002-10-17 | Sun Pharmaceutical Industries Limited | Timed pulse release composition |
US7538082B2 (en) | 2001-04-24 | 2009-05-26 | The General Hospital Corporation | Methods and compositions for treating oral and esophageal lesions |
US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
US20030032631A1 (en) * | 2001-08-13 | 2003-02-13 | Mcdonald George B. | Method of treatment of cancer by controlling graft-versus-leukemia using topical active corticosteriods |
TWI252111B (en) * | 2001-12-14 | 2006-04-01 | Solvay Pharm Gmbh | Matrix film tablet with controlled release of a natural mixture of conjugated estrogens |
AU2002357935A1 (en) * | 2001-12-18 | 2003-06-30 | Alza Corporation | Dosage form for providing time-varying patterns of drug delivery |
AU2003231777C1 (en) * | 2002-04-29 | 2009-10-29 | Supernus Pharmaceuticals, Inc. | Pharmaceutical formulations with improved bioavailability |
NZ519363A (en) * | 2002-06-05 | 2004-02-27 | Agres Ltd | A novel drug dosing regimen |
FR2843302B1 (fr) * | 2002-08-09 | 2004-10-22 | Centre Nat Rech Scient | Forme galenique pour la delivrance colique de principes actifs |
JP2006503045A (ja) * | 2002-09-16 | 2006-01-26 | ワイエス | ポリペプチド治療薬剤の経口投与のための遅延放出処方物と同薬剤の使用方法 |
US20060210633A1 (en) * | 2003-04-03 | 2006-09-21 | Sun Pharmaceutical Industries Limited | Programmed drug delivery system |
US20060177507A1 (en) * | 2003-05-22 | 2006-08-10 | Joaquina Faour | Controlled release device containing lercanidipine |
US8029822B2 (en) * | 2003-05-22 | 2011-10-04 | Osmotica Kereskedelmi és Seolgáltató KFT | Rupturing controlled release device having a preformed passageway |
US20050013863A1 (en) | 2003-07-18 | 2005-01-20 | Depomed, Inc., A Corporation Of The State Of California | Dual drug dosage forms with improved separation of drugs |
IL158658A0 (en) * | 2003-10-29 | 2004-05-12 | Moshe Schwarzberg | Prokinetic drugs assistance to small intestine imaging |
EP1680100A4 (de) | 2003-11-04 | 2012-08-08 | Supernus Pharmaceuticals Inc | Zusammensetzungen aus quartärem ammonium mit biologisch verfügbaren verstärkern |
EP2210605B1 (de) * | 2003-11-04 | 2017-03-01 | TCD Royalty Sub, LLC | Einmal tägliche Dosierungsformen von Trospium |
US7943585B2 (en) | 2003-12-22 | 2011-05-17 | Sandoz, Inc. | Extended release antibiotic composition |
EP1750862B1 (de) | 2004-06-04 | 2011-01-05 | Teva Pharmaceutical Industries Ltd. | Irbesartan enthaltende pharmazeutische zusammensetzung |
WO2006014427A1 (en) * | 2004-07-02 | 2006-02-09 | Advancis Pharmaceutical Corporation | Tablet for pulsed delivery |
FR2874325B1 (fr) * | 2004-08-19 | 2006-10-20 | Sanofi Synthelabo | Composition pharmaceutique sous forme de comprime a residence gastrique contenant de l'alfuzosine |
AR051654A1 (es) * | 2004-11-04 | 2007-01-31 | Astrazeneca Ab | Nuevas formulaciones de pellets de liberacion modificada para inhibidores de la bomba de protones |
AR052225A1 (es) * | 2004-11-04 | 2007-03-07 | Astrazeneca Ab | Formulaciones de tabletas de liberacion modificada par inhibidores de la bomba de protones |
FR2878159B1 (fr) * | 2004-11-24 | 2008-10-17 | Flamel Technologies Sa | Medicament oral a liberation modifiee d'au moins un principe actif sous forme multimicrocapsulaire |
AU2005320547B2 (en) | 2004-12-27 | 2009-02-05 | Eisai R & D Management Co., Ltd. | Method for stabilizing anti-dementia drug |
US20070129402A1 (en) * | 2004-12-27 | 2007-06-07 | Eisai Research Institute | Sustained release formulations |
US20060165797A1 (en) * | 2005-01-12 | 2006-07-27 | Pozen Inc. | Dosage form for treating gastrointestinal disorders |
CN101128187A (zh) * | 2005-02-09 | 2008-02-20 | 达沃尔泰拉公司 | 活性剂的结肠递送 |
CA2600736A1 (en) * | 2005-03-16 | 2006-09-21 | Dr. Reddy's Laboratories Ltd. | Delivery system for multiple drugs |
EA200702221A1 (ru) * | 2005-04-12 | 2008-04-28 | Элан Фарма Интернэшнл Лимитед | Композиции с контролируемым высвобождением для лечения бактериальной инфекции, содержащие цефалоспорин |
US20060257473A1 (en) * | 2005-05-11 | 2006-11-16 | Porranee Puranajoti | Extended release tablet |
US20060280795A1 (en) * | 2005-06-08 | 2006-12-14 | Dexcel Pharma Technologies, Ltd. | Specific time-delayed burst profile delivery system |
ES2560240T5 (es) * | 2005-07-29 | 2022-11-08 | Stichting Groningen Centre For Drug Res | Sistema de suministro pulsátil controlado por pH, métodos para la preparación y uso del mismo |
US8778395B2 (en) * | 2005-08-11 | 2014-07-15 | Andrx Labs, Llc | Diltiazem controlled release formulation and method of manufacture |
EP1945188A2 (de) * | 2005-11-07 | 2008-07-23 | Teva Pharmaceutical Industries Ltd. | Levodopa-zusammensetzung |
WO2007103557A2 (en) | 2006-03-09 | 2007-09-13 | Reliant Pharmaceuticals, Inc. | Coating capsules with active pharmaceutical ingredients |
US8784886B2 (en) * | 2006-03-09 | 2014-07-22 | GlaxoSmithKline, LLC | Coating capsules with active pharmaceutical ingredients |
US7570986B2 (en) * | 2006-05-17 | 2009-08-04 | The United States Of America As Represented By The Secretary Of Health And Human Services | Teniae coli guided navigation and registration for virtual colonoscopy |
WO2008003043A2 (en) | 2006-06-28 | 2008-01-03 | Surmodics, Inc. | Combination degradable and non-degradable matrices for active agent delivery |
EP2079448A2 (de) * | 2006-10-10 | 2009-07-22 | Dexcel Pharma Technologies Ltd. | Verbesserte freisetzung von statinen im darm |
US7731604B2 (en) * | 2006-10-31 | 2010-06-08 | Taylor Made Golf Company, Inc. | Golf club iron head |
US8273376B2 (en) * | 2006-11-17 | 2012-09-25 | Da Volterra | Colonic delivery of metallo-dependent enzymes |
US20080124279A1 (en) * | 2006-11-17 | 2008-05-29 | Antoine Andremont | Colonic delivery using Zn/pectin beads with a Eudragit coating |
CA2923102C (en) * | 2007-08-13 | 2019-10-15 | Abuse Deterrent Pharmaceutical Llc | Abuse resistant drugs, method of use and method of making |
US20090194533A1 (en) | 2008-02-04 | 2009-08-06 | Lizerbram Eric K | Closure with additive reservoir |
US9220698B2 (en) | 2008-09-09 | 2015-12-29 | Pozen Inc. | Method for delivering a pharmaceutical composition to patient in need thereof |
EP2179727B1 (de) * | 2008-10-27 | 2013-05-29 | Roquette Freres | Folienbeschichtungen aus wasserunlöslichem Polymer und modifiziertem Stärkederivat zur Dickdarmansteuerung |
CN102245171A (zh) * | 2008-11-10 | 2011-11-16 | 株式会社爱茉莉太平洋 | 缓释微粒及其制备方法 |
EP2405901A1 (de) | 2009-03-09 | 2012-01-18 | Council of Scientific & Industrial Research | Zusammensetzung eines therapeutischen mittels mit gepulster freisetzung |
TWI478733B (zh) * | 2009-05-13 | 2015-04-01 | Wyeth Llc | 突釋藥物釋放組合物 |
EA201290026A1 (ru) | 2009-06-25 | 2012-07-30 | Астразенека Аб | Способ лечения пациента, имеющего риск развития язвы, связанной с приемом нестероидных противовоспалительных средств (nsaid) |
EP2498764B1 (de) | 2009-11-09 | 2017-09-06 | Spotlight Technology Partners LLC | Fragmentierte hydrogele |
CA2780294C (en) | 2009-11-09 | 2018-01-16 | Spotlight Technology Partners Llc | Polysaccharide based hydrogels |
EP2356984A1 (de) * | 2010-02-04 | 2011-08-17 | Nycomed Austria GmbH | Verbesserte Distigminbromidformulierung |
GB201003766D0 (en) | 2010-03-05 | 2010-04-21 | Univ Strathclyde | Pulsatile drug release |
GB201003731D0 (en) * | 2010-03-05 | 2010-04-21 | Univ Strathclyde | Immediate/delayed drug delivery |
GB201003734D0 (en) | 2010-03-05 | 2010-04-21 | Univ Strathclyde | Delayed prolonged drug delivery |
CN102258492B (zh) * | 2010-05-24 | 2012-12-26 | 重庆医科大学 | 溴新斯的明缓释片剂及其制备方法 |
IT1402047B1 (it) * | 2010-10-19 | 2013-08-28 | Cross Pharma Sa | Uso del mexiprostil nel trattamento delle malattie infiammatorie intestinali |
US8911780B2 (en) | 2011-02-11 | 2014-12-16 | Zx Pharma, Llc | Multiparticulate L-menthol formulations and related methods |
PL2672981T3 (pl) | 2011-02-11 | 2018-09-28 | Zx Pharma, Llc | Wielocząstkowe preparaty l-mentolu i powiązane sposoby |
US8808736B2 (en) | 2011-02-11 | 2014-08-19 | Zx Pharma, Llc | Enteric coated multiparticulate controlled release peppermint oil composition and related methods |
JP6121990B2 (ja) * | 2011-05-13 | 2017-04-26 | イービー アイピー ハイブリタブス ビー.ブイ. | 薬物送達システム |
UA115139C2 (uk) | 2011-12-28 | 2017-09-25 | Поузен Інк. | Спосіб доставки фармацевтичної композиції, яка містить омепразол й ацетилсаліцилову кислоту, пацієнту |
DK3326611T3 (da) | 2012-02-22 | 2020-08-17 | Duchesnay Inc | Formulering af doxylamin og pyridoxin og / eller metaboliter eller salt deraf |
CN102675693B (zh) * | 2012-05-04 | 2013-11-13 | 浦江县鑫平进出口有限公司 | 一种透明鼻涕胶及其制备方法 |
US8859005B2 (en) | 2012-12-03 | 2014-10-14 | Intercontinental Great Brands Llc | Enteric delivery of functional ingredients suitable for hot comestible applications |
CN103191464B (zh) * | 2013-04-07 | 2014-07-02 | 西南交通大学 | 一种抗菌多孔氧化石墨烯/壳聚糖复合支架的制备方法 |
CN103191469B (zh) * | 2013-04-08 | 2014-07-02 | 西南交通大学 | 一种在骨损伤修复材料表面制备载生长因子涂层的方法 |
LT2988824T (lt) | 2013-04-23 | 2019-02-25 | Zx Pharma, Llc | Žarnyno turiniui atspariu dangalu padengta multidalelių kompozicija su baltyminiu pagalbiniu dangalu |
NZ716017A (en) | 2013-07-22 | 2020-07-31 | Duchesnay Inc | Composition for the management of nausea and vomiting |
KR20170023776A (ko) | 2014-02-26 | 2017-03-06 | 루마 세러퓨틱스 인코포레이티드 | 자외선 광선 치료 장치들 및 방법들 |
IL253802B (en) | 2015-02-09 | 2022-06-01 | Entera Bio Ltd | A preparation for the treatment of osteoporosis |
WO2017139514A1 (en) | 2016-02-09 | 2017-08-17 | Luma Therapeutics, Inc. | Methods, compositions and apparatuses for treating psoriasis by phototherapy |
US20190111001A1 (en) * | 2016-03-30 | 2019-04-18 | University Of Maryland, Baltimore | Microparticulate system for colonic drug delivery |
EP3225566B1 (de) * | 2016-03-31 | 2018-09-05 | Axel Nickel | Getränkepulver enthaltende kapsel, insbesondere zur zubereitung von gebrühtem kaffee |
US20190381056A1 (en) | 2018-06-17 | 2019-12-19 | Axsome Therapeutics, Inc. | Compositions for delivery of reboxetine |
US11020402B2 (en) | 2018-10-15 | 2021-06-01 | Axsome Therapeutics, Inc. | Use of reboxetine to treat narcolepsy |
US20200147093A1 (en) | 2018-10-15 | 2020-05-14 | Axsome Therapeutics, Inc. | Use of esreboxetine to treat nervous system disorders such as fibromyalgia |
BR112022011714A2 (pt) | 2019-12-17 | 2022-09-06 | 9286 3620 Quebec Inc | Sistemas de distribuição oral com base em formação in situ de coacervados de proteína/polissacarídeo |
US11833231B2 (en) * | 2020-10-19 | 2023-12-05 | The Procter & Gamble Company | Oral care article comprising a delivery carrier and solid hydrophilic particles comprising a bleaching agent |
WO2022101267A2 (en) * | 2020-11-12 | 2022-05-19 | Da Volterra | Compositions for delivery of an adsorbent |
JP2023553202A (ja) | 2020-12-08 | 2023-12-20 | ルミナント バイオテク コーポレーション リミテッド | 動物に物質を送達するための装置および方法の改善 |
WO2023107715A1 (en) * | 2021-12-09 | 2023-06-15 | Tactogen Inc | Specialized combinations for mental disorders or mental enhancement |
Family Cites Families (79)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3247066A (en) | 1962-09-12 | 1966-04-19 | Parke Davis & Co | Controlled release dosage form containing water-swellable beadlet |
US3921636A (en) | 1973-01-15 | 1975-11-25 | Alza Corp | Novel drug delivery device |
US4107288A (en) | 1974-09-18 | 1978-08-15 | Pharmaceutical Society Of Victoria | Injectable compositions, nanoparticles useful therein, and process of manufacturing same |
JPS5186117A (en) | 1975-01-27 | 1976-07-28 | Tanabe Seiyaku Co | Johoseibiryushiseizainoseiho |
GB1538075A (en) | 1975-03-24 | 1979-01-10 | Champion Paper Co Ltd | Formation of microcapsules by interfacial cross-linking and microcapsules produced thereby |
US4344857A (en) | 1975-12-22 | 1982-08-17 | The United States Of America As Represented By The Secretary Of Agriculture | Encapsulation by entrapment |
US4277364A (en) | 1975-12-22 | 1981-07-07 | The United States Of America As Represented By The Secretary Of Agriculture | Encapsulation by entrapment |
US4169804A (en) | 1976-08-19 | 1979-10-02 | Minnesota Mining And Manufacturing Company | Magnetically responsive composite microparticle |
DE2712161C2 (de) | 1977-03-19 | 1983-01-05 | Blendax-Werke R. Schneider Gmbh & Co, 6500 Mainz | Zahn- und Mundpflegemittel |
US4307717A (en) | 1977-11-07 | 1981-12-29 | Lectec Corporation | Sterile improved bandage containing a medicament |
US4279812A (en) | 1979-09-12 | 1981-07-21 | Seton Company | Process for preparing macromolecular biologically active collagen |
US4252786A (en) | 1979-11-16 | 1981-02-24 | E. R. Squibb & Sons, Inc. | Controlled release tablet |
FR2471186A1 (fr) | 1979-12-10 | 1981-06-19 | Roussel Uclaf | Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation |
JPS5911563B2 (ja) | 1980-02-27 | 1984-03-16 | 日本原子力研究所 | 多層構造の徐放性複合体を製造する方法 |
US4348384A (en) | 1980-10-17 | 1982-09-07 | Dainippon Pharmaceutical Co., Ltd. | Pharmaceutical composition for oral administration containing coagulation factor VIII or IX |
US4327725A (en) | 1980-11-25 | 1982-05-04 | Alza Corporation | Osmotic device with hydrogel driving member |
US4349530A (en) | 1980-12-11 | 1982-09-14 | The Ohio State University | Implants, microbeads, microcapsules, preparation thereof and method of administering a biologically-active substance to an animal |
US4442655A (en) | 1981-06-25 | 1984-04-17 | Serapharm Michael Stroetmann | Fibrinogen-containing dry preparation, manufacture and use thereof |
JPS5867616A (ja) | 1981-10-15 | 1983-04-22 | Tanabe Seiyaku Co Ltd | 腸溶性マイクロカプセル |
JPS59222406A (ja) | 1983-06-01 | 1984-12-14 | Teijin Ltd | 歯周疾患治療用製剤及びその製造法 |
CA1196863A (en) | 1983-06-08 | 1985-11-19 | Mattheus F.A. Goosen | Slow release injectable insulin composition |
JPS60501759A (ja) | 1983-07-01 | 1985-10-17 | バテル メモリアル インステイチユ−ト | 生物分解性ポリペプチド及び薬剤の緩慢な放出のためのその使用 |
US4627850A (en) | 1983-11-02 | 1986-12-09 | Alza Corporation | Osmotic capsule |
CA1295796C (en) | 1984-03-27 | 1992-02-18 | Conrad Whyne | Biodegradable matrix and methods for producing same |
US4619913A (en) | 1984-05-29 | 1986-10-28 | Matrix Pharmaceuticals, Inc. | Treatments employing drug-containing matrices for introduction into cellular lesion areas |
US4610870A (en) | 1984-10-05 | 1986-09-09 | E. R. Squibb & Sons, Inc. | Controlled release formulation |
US4678516A (en) | 1984-10-09 | 1987-07-07 | The Dow Chemical Company | Sustained release dosage form based on highly plasticized cellulose ether gels |
US4568536A (en) | 1985-02-08 | 1986-02-04 | Ethicon, Inc. | Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition |
GB8518301D0 (en) | 1985-07-19 | 1985-08-29 | Fujisawa Pharmaceutical Co | Hydrodynamically explosive systems |
GB8524001D0 (en) | 1985-09-30 | 1985-11-06 | Glaxo Group Ltd | Pharmaceutical composition |
US4794002A (en) | 1985-11-01 | 1988-12-27 | Monsanto Company | Modified polymeric surfaces and process for preparing same |
EP0250374B1 (de) | 1986-06-17 | 1991-05-02 | RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.p.a. | Therapeutisches System mit geregelter Wirkstoffabgabe |
US4803075A (en) | 1986-06-25 | 1989-02-07 | Collagen Corporation | Injectable implant composition having improved intrudability |
GB2203143B (en) | 1987-03-20 | 1991-06-05 | Central Glass Co Ltd | Multilayer foam glass with dense glass surface layer and method of producing same |
NO883326L (no) * | 1987-08-11 | 1989-02-13 | Bayer Ag | Dhp-retard-tilberedning. |
US4891223A (en) | 1987-09-03 | 1990-01-02 | Air Products And Chemicals, Inc. | Controlled release delivery coating formulation for bioactive substances |
US4904474A (en) | 1988-01-25 | 1990-02-27 | Alza Corporation | Delivery of drug to colon by oral disage form |
ATE79029T1 (de) | 1989-02-11 | 1992-08-15 | Bayer Ag | Arzneimittel mit kontrollierter wirkstoffabgabe. |
EP0408496A3 (en) | 1989-07-12 | 1992-07-01 | Ciba-Geigy Ag | Solid dosage form for pharmaceutical substances |
US5229131A (en) | 1990-02-05 | 1993-07-20 | University Of Michigan | Pulsatile drug delivery system |
IL98087A (en) | 1990-05-04 | 1996-11-14 | Perio Prod Ltd | Preparation for dispensing drugs in the colon |
AU659106B2 (en) | 1990-11-06 | 1995-05-11 | Fgn, Inc. | Method for treating colonic polyps by the use of esters and amides of substituted phenyl and pyridyl amino carboxylates |
AU659107B2 (en) | 1990-11-06 | 1995-05-11 | Fgn, Inc. | Method for treating colonic polyps by the use of esters and amides of substituted fused ring phenyl acetic acids |
AU658373B2 (en) | 1990-11-06 | 1995-04-13 | Fgn, Inc. | Esters and amides of substituted pyrrole acetic acids |
AU650914B2 (en) | 1990-11-06 | 1994-07-07 | Fgn, Inc. | Esters and amides of substituted phenyl acetic acids |
AU650689B2 (en) | 1990-11-06 | 1994-06-30 | Fgn, Inc. | Esters and amides of substituted indenyl acetic acids |
DE9015551U1 (de) | 1990-11-14 | 1992-03-12 | Roehm Gmbh, 6100 Darmstadt, De | |
US5422121A (en) | 1990-11-14 | 1995-06-06 | Rohm Gmbh | Oral dosage unit form |
DE69202721T2 (de) | 1991-03-08 | 1995-10-12 | Fgn Inc | Substituierte Indenylverbindungen. |
US5401774A (en) | 1991-03-08 | 1995-03-28 | University Of Arizona | Method for treating patients with precancerous lesions by administering substituted sulfonyl idenyl acetic and propionic acids and esters to patients with lesions sensitive to such compounds |
US5654009A (en) | 1991-03-25 | 1997-08-05 | Fujisawa Pharmaceutical Co., Ltd. | Delayed action preparation |
EP0576675A4 (en) | 1991-03-25 | 1994-06-01 | Fujisawa Pharmaceutical Co | Long-acting pharmaceutical preparation |
NZ286242A (en) | 1991-03-26 | 1997-11-24 | Csl Ltd | Use of veterinary implant as a single dose vaccination system: rupturable polymer film coating around core of active agent and water soluble excipient |
WO1992020369A1 (en) | 1991-05-14 | 1992-11-26 | Dana Farber Cancer Institute | Use of hemoglobin in a method for the treatment of tumors with chemotherapeutic agents |
DE69222006T2 (de) * | 1991-10-30 | 1998-01-22 | Glaxo Group Ltd | Mehrschichtzusammensetzungen enthaltend Histamin- oder Serotonin- Antagonisten |
US5162117A (en) * | 1991-11-22 | 1992-11-10 | Schering Corporation | Controlled release flutamide composition |
DE4209160A1 (de) | 1992-03-20 | 1993-09-30 | Bauer Kurt Heinz Prof Dr | Vernetzte Polysaccharide, Verfahren zu ihrer Herstellung und ihre Verwendung |
US5260068A (en) | 1992-05-04 | 1993-11-09 | Anda Sr Pharmaceuticals Inc. | Multiparticulate pulsatile drug delivery system |
IT1260505B (it) | 1992-06-01 | 1996-04-09 | Poli Ind Chimica Spa | Sistemi farmaceutici orali a cessione ritardata per il rilascio specifico nel colon |
US5260069A (en) | 1992-11-27 | 1993-11-09 | Anda Sr Pharmaceuticals Inc. | Pulsatile particles drug delivery system |
US5358502A (en) | 1993-02-25 | 1994-10-25 | Pfizer Inc | PH-triggered osmotic bursting delivery devices |
US5651983A (en) | 1993-02-26 | 1997-07-29 | The Procter & Gamble Company | Bisacodyl dosage form for colonic delivery |
US5656290A (en) | 1993-02-26 | 1997-08-12 | The Procter & Gamble Company | Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery |
US5686105A (en) | 1993-10-19 | 1997-11-11 | The Procter & Gamble Company | Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery |
US5514663A (en) | 1993-10-19 | 1996-05-07 | The Procter & Gamble Company | Senna dosage form |
JP3725542B2 (ja) | 1993-10-19 | 2005-12-14 | 大正製薬株式会社 | ピコサルフェート剤形 |
US5498608A (en) | 1994-01-07 | 1996-03-12 | Salix Pharmaceuticals | Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents |
JPH07223970A (ja) | 1994-02-10 | 1995-08-22 | Tanabe Seiyaku Co Ltd | 消化管内適所放出製剤 |
US5464633A (en) | 1994-05-24 | 1995-11-07 | Jagotec Ag | Pharmaceutical tablets releasing the active substance after a definite period of time |
US5531735A (en) | 1994-09-27 | 1996-07-02 | Hercules Incorporated | Medical devices containing triggerable disintegration agents |
US5622948A (en) | 1994-12-01 | 1997-04-22 | Syntex (U.S.A.) Inc. | Pyrrole pyridazine and pyridazinone anti-inflammatory agents |
US5686106A (en) | 1995-05-17 | 1997-11-11 | The Procter & Gamble Company | Pharmaceutical dosage form for colonic delivery |
US5945124A (en) | 1995-07-05 | 1999-08-31 | Byk Gulden Chemische Fabrik Gmbh | Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole |
DE29680627U1 (de) | 1995-07-20 | 1999-06-02 | Juergens Uwe R Dr Med | Nicht-steroidales Antiphlogistikum zur topischen und systemischen Behandlung der akuten und chronischen polypoiden Rhinosinusitis |
US5840332A (en) | 1996-01-18 | 1998-11-24 | Perio Products Ltd. | Gastrointestinal drug delivery system |
US5780055A (en) | 1996-09-06 | 1998-07-14 | University Of Maryland, Baltimore | Cushioning beads and tablet comprising the same capable of forming a suspension |
US5874418A (en) | 1997-05-05 | 1999-02-23 | Cydex, Inc. | Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use |
US5840329A (en) | 1997-05-15 | 1998-11-24 | Bioadvances Llc | Pulsatile drug delivery system |
JP2001519379A (ja) | 1997-10-09 | 2001-10-23 | ペリオ、プロダクツ、リミテッド | 遅延性総放出胃腸薬物送達システム |
-
1999
- 1999-06-04 US US09/325,748 patent/US6632451B2/en not_active Expired - Fee Related
-
2000
- 2000-06-02 DE DE60016920T patent/DE60016920T2/de not_active Expired - Lifetime
- 2000-06-02 AU AU54582/00A patent/AU780141B2/en not_active Ceased
- 2000-06-02 AT AT00939503T patent/ATE285228T1/de not_active IP Right Cessation
- 2000-06-02 WO PCT/US2000/015185 patent/WO2000074655A2/en active IP Right Grant
- 2000-06-02 EP EP00939503A patent/EP1189601B1/de not_active Expired - Lifetime
- 2000-06-02 CA CA002375714A patent/CA2375714C/en not_active Expired - Fee Related
- 2000-06-02 IL IL14670800A patent/IL146708A0/xx active IP Right Grant
-
2001
- 2001-11-23 IL IL146708A patent/IL146708A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2375714A1 (en) | 2000-12-14 |
DE60016920D1 (de) | 2005-01-27 |
IL146708A (en) | 2008-06-05 |
EP1189601B1 (de) | 2004-12-22 |
WO2000074655A3 (en) | 2001-08-30 |
EP1189601A2 (de) | 2002-03-27 |
AU5458200A (en) | 2000-12-28 |
WO2000074655A2 (en) | 2000-12-14 |
WO2000074655A9 (en) | 2001-04-12 |
IL146708A0 (en) | 2002-07-25 |
US20020110593A1 (en) | 2002-08-15 |
CA2375714C (en) | 2008-10-07 |
AU780141B2 (en) | 2005-03-03 |
US6632451B2 (en) | 2003-10-14 |
DE60016920T2 (de) | 2006-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE285228T1 (de) | Arzneistoffverabreichungsystem zur verzögerten, völlstandigen wirkstoffabgabe im verdauungstrakt | |
ATE238774T1 (de) | Darreichungsform zur verzögerten, vollständigen wirkstoffabgabe im verdauungstrakt | |
US4898733A (en) | Layered, compression molded device for the sustained release of a beneficial agent | |
US5681584A (en) | Controlled release drug delivery device | |
US20220125739A1 (en) | Abuse and Misuse Deterrent Transdermal Systems | |
DK0673645T3 (da) | Farmaceutisk præparat til afgivelse af lægemidler i colon | |
ATE377414T1 (de) | Mikropartikel, geeignet als kontrastmittel im ultraschall und zur wirkstoffgabe in den blutkreislauf | |
WO2004087011A3 (en) | Therapeutic agent delivery device with controlled therapeutic agent release rates | |
CA2179894A1 (en) | Transdermal drug delivery system | |
HUT54038A (en) | Process for producing compositions with hydrogel-operated controlled release of active ingredient | |
MXPA02007762A (es) | Sistema de suministro de farmaco pulsativos temporalizados. | |
WO2001043749A3 (en) | Pharmaceutical implant containing immediate-release and sustained-release components and method of administration | |
EP2260836A3 (de) | Schnellfreisetzende Tablette mit beschichtetem, wirkstoffhaltigem Kern und umgebender Schicht als Geschmacksbarriere | |
Shanmugan et al. | Chronotherapeutic drug delivery systems | |
Patil et al. | Patented pulsatile drug delivery technologies for chronotherapy | |
ATE361060T1 (de) | Ionenstärkenunabhängige pharmazeutische formulierung mit verzögerter freisetzung | |
PT96921B (pt) | Dispositivo de libertacao intermitente | |
Sarkhejiya et al. | Newer insights into pulsatile drug delivery systems | |
Sendil-Keskin et al. | In vivo pain relief effectiveness of an analgesic-anesthetic carrying biodegradable controlled release rod systems | |
Saha et al. | Switch to Modern Pulsatile Capsule Technology | |
Stevens | Chronopharmaceutical drug delivery | |
Marzouk | Pulsatile Drug Delivery Systems: A Review | |
Kothawade et al. | Chronotherapy: A New Branch of Therapy | |
CA2243863A1 (en) | Gastrointestinal drug delivery system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |